Keywords: Avanir Pharma, Concert Pharma, Nervous system disorders, Licensing accord

Avanir and Concert Pharma link up for nervous system disorders

Article | 01 March 2012

USA-based companies Avanir Pharmaceuticals (Nasdaq: AVNR) and Concert Pharmaceuticals have entered into an exclusive license agreement that provides Avanir worldwide ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in